Johnson & Johnson submitted its one-shot Covid-19 vaccine for FDA authorization, saying it expects to supply 100 million doses to the U.S. in the first half of 2021 on.wsj.com
@WSJ4 years ago
Johnson & Johnson submitted its one-shot Covid-19 vaccine for FDA authorization, saying it expects to supply 100 million doses to the U.S. in the first half of 2021 on.wsj.com
